comparemela.com

Latest Breaking News On - Laurae niklason - Page 1 : comparemela.com

Humacyte, Inc (NASDAQ:HUMA) Short Interest Up 10 7% in November

Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) was the recipient of a significant growth in short interest in November. As of November 15th, there was short interest totalling 6,090,000 shares, a growth of 10.7% from the October 31st total of 5,500,000 shares. Based on an average daily trading volume, of 583,200 shares, the short-interest ratio […]

Humacyte, Inc (NASDAQ:HUMA) Short Interest Update

Humacyte, Inc (NASDAQ:HUMA) Short Interest Update
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Humacyte, Inc (NASDAQ:HUMA) Short Interest Up 38 2% in September

Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) was the target of a large growth in short interest in September. As of September 15th, there was short interest totalling 5,250,000 shares, a growth of 38.2% from the August 31st total of 3,800,000 shares. Based on an average trading volume of 670,100 shares, the short-interest ratio is […]

Cantor Fitzgerald Reiterates Overweight Rating for Humacyte (NASDAQ:HUMA)

Cantor Fitzgerald reaffirmed their overweight rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a research note issued to investors on Thursday morning, Benzinga reports. Cantor Fitzgerald currently has a $6.00 price objective on the stock. Several other brokerages have also recently weighed in on HUMA. Benchmark reiterated a buy rating and issued a […]

Humacyte (NASDAQ:HUMA) Earns Overweight Rating from Cantor Fitzgerald

Cantor Fitzgerald reaffirmed their overweight rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a $6.00 target price on the stock. A number of other analysts have also weighed in on HUMA. Benchmark reaffirmed a buy rating and issued a […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.